Open to opportunities

Kalyan PM

@kalyanpm

Message

PhD researcher specializing in finance and investment strategies.

Sweden

Message

What I'm looking for

I am seeking a role that fosters innovation in finance, encourages collaboration, and offers opportunities for professional growth.

I am a dedicated doctoral researcher in finance at Lund University, where I have developed innovative frameworks that significantly enhance investment strategies. My work has led to a remarkable increase in exit success rates for early-stage investors, demonstrating my ability to apply advanced statistical techniques to real-world challenges.

With experience as an Investment Strategy Associate at Value Invest SA, I successfully navigated the complexities of the pandemic to secure substantial capital and achieve impressive portfolio growth. My analytical skills and strategic thinking have consistently driven results, allowing me to implement effective sector rotation strategies and optimize risk-adjusted returns.

My academic journey has been marked by excellence, including a top 5% presenter slot at the ESU Doctoral Consortium and recognition through the Ruben Rausing Endowment. I am passionate about leveraging my expertise in finance to contribute to impactful investment strategies and drive organizational success.

Experience

Work history, roles, and key accomplishments

Current

Doctoral Researcher (Finance)

Current

Lund University

Sep 2019 - Oct 2024 (5 years 1 month)

Conducted advanced research in finance, significantly improving exit success rates for investors through innovative strategic frameworks and statistical techniques. Developed scalable exit strategies and mapped investment patterns in Sweden's angel groups and micro-VCs.

Statistical Analysis Quantitative Analysis

Investment Strategy Associate

Value Invest SA

Feb 2021 - Sep 2023 (2 years 7 months)

Secured significant capital during market uncertainty by crafting adaptive investment proposals. Achieved notable NAV growth through strategic sector rotations and optimized portfolio management using automated screening.

Proposals NAV Growth Sector Rotation Strategies Portfolio Management Risk Assessment

Corporate Strategy Analyst (M&A)

Aurobindo Pharmaceuticals Ltd.

Jan 2017 - Sep 2017 (8 months)

Developed market entry strategies for the biosimilars market, leading investment initiatives and aligning stakeholders through comprehensive analyses and strategic planning.

Market Entry Strategy Cost Benefit Analysis Risk Assessment

Education

Degrees, certifications, and relevant coursework

Lund University

PhD, Finance

2019 - 2024

Thesis: Achieved a unanimous 3/3 vote from the grading committee at the defense, with no further comments for thesis Business Angel Groups and Exit Strategies: A Mixed Methods Approach. Award: Recipient of the prestigious Ruben Rausing Endowment from Tetra Laval (2019); Awarded a top 5% presenter slot (15/300 applicants) to present research findings for the ESU Doctoral Consortium (2022) at the Un

Cranfield University

MSc, Finance & Management

2017 - 2018

Grade: Passed with distinction (Top 5% of the class)

Thesis: Identified that underpriced VC-backed firms with high media sentiment achieved 18% higher 3-year returns than peers by analysing IPO underpricing effects using NLP-driven sentiment analysis.

Osmania University

Bachelor's, Commerce (Accounting)

2014 - 2017

Grade: 8.4/10

Activities and societies: Elected Student Leader, University Event Lead Organizer and Host

GPA: 8.4/10 (Top 3% of University). Activities: Elected Student Leader (3H a week), University Event Lead Organizer and Host (5H a Month). Award: State Debate Champion (2015), Athletics (Gold Medal in 100m sprint at University Sports Meet).